Indications, mechanism of action, administration, side effects and precautions of osimertinib/osimertinib

Osimertinib (Osimertinib) is an oral targeted therapy drug used to treat EGFR (epidermal growth factor receptor) gene mutation-positive advanced non-small cell lung cancer (NSCLC). The following is a detailed introduction to the indications, mechanism of action, administration, side effects and precautions of osimertinib/osimertinib:

1.Indications:

Osimertinib/Osimertinib is mainly suitable for patients with EGFR gene mutation-positive advanced non-small cell lung cancer (NSCLC).

Especially suitable for patients who have developed resistance to otherEGFRinhibitors.

Applicable to patients with Del19, L858R or T790M and other EGFR mutations.

2.Mechanism of action:

Osimertinib/Osimertinib is a third-generation EGFRtyrosine kinase inhibitor with higher selectivity than other EGFR inhibitors.

The mechanism of action is to interfere with the growth, proliferation and survival of tumor cells by inhibiting the EGFR signaling pathway, thereby inhibiting tumor development and metastasis.

Specifically targetsEGFR mutations and drug-resistant mutations, reducing toxic side effects on normal cells.

3.How to take:

Osimertinib/Osimertinibis usually given as an oral tablet.

Each dose is 80 milligrams (mg) once a day.

It can be taken with food or on an empty stomach. It is recommended to take it on an empty stomach or 2 hours after a meal.

The tablets should be swallowed whole and mixed with a sufficient amount of water (approximately200ml).

It is not recommended to chew osimertinib/osimertinib tablets or divide them in half to avoid affecting the release rate and absorption effect of the drug.

4.Side effects:

Osimertinib/OsimertinibCommon side effects include rash, diarrhea, drowsiness, fatigue, cough, etc.

Severe adverse reactions may include interstitial pneumonia, cardiovascular events, visual impairment, etc.

Patients should pay close attention to their own conditions during medication and report any symptoms of discomfort to their doctors in a timely manner.

5.Notes:

During treatment, patients should undergo regular clinical evaluations, imaging studies, and laboratory tests to monitor disease progression and treatment effects.

Based on the patient's specific situation, the doctor may adjust the dosage or take other treatment measures.

For special groups, such as elderly patients, patients with impaired liver function, patients with impaired renal function and pregnant women, osimertinib/osimertinib should be used with caution, and the dose should be adjusted according to the specific situation.

Patients should avoid interactions with other drugs during medication, especially inhibitors and inducers of CYP3A4 and P-gp, so as not to affect the pharmacokinetics of osimertinib/osimertinib.

To sum up, Osimertinib/Osimertinib is a targeted therapy drug with clear indications, mechanism of action and medication method. When using osimertinib/osimertinib, patients should strictly abide by the doctor's instructions and report any adverse reactions in a timely manner to ensure the safety and effectiveness of the treatment.